[1]Drug-induced Liver Disease Study Group,Chinese Society of Hepatology,Chinese Medical Association.Guidelines for the management of drug-induced liver injury[J].J Clin Hepatol,2015,31(11):1752-1769.(in Chinese)中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志,2015,31(11):1752-1769.
|
[2]DANAN G,TESCHKE R.RUCAM in drug and herb induced liver injury:the update[J].Int J Mol Sci,2015,17(1).pii:e14.
|
[3] Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medical Association;Chinese Society of Infectious Diseases,Chinese Medical Association.Consensus on the diagnosis and treatment of cholestasis liver diseases(2015)[J].J Clin Hepatol,2015,31(12):1989-1999.(in Chinese)中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会.胆汁淤积性肝病诊断和治疗共识(2015)[J].临床肝胆病杂志,2015,31(12):1989-1999.
|
[4]HAYASHI PH,FONTANA RJ.Clinical features,diagnosis and natural history of drug-induced liver injury[J].Semin Liver Dis,2014,34(2):134-144.
|
[5]BJRNSSON E,TALWALKAR J,TREEPRASERTSUK S,et al.Drug induced autoimmune hepatitis:clinical characteristics and prognosis[J].Hepatology,2010,51(6):2040-2048.
|
[6]CASTIELLA A,LUCENA MI,ZAPATA EM,et al.Drug-induced autoimmune-like hepatitis:a diagnostic challenge[J].Dig Dis Sci,2011,56(8):2501-252.
|
[7]ANDRADE RJ,LUCENA MI,KAPLOWITZ N,et al.Outcome of acute idiosyncratic drug-induced liver injury:long-term follow-up in a hepatotoxicity registry[J].Hepatology,2006,44(6):1581-1588.
|